Novan, Inc. NOVN
0.09 0.00 (+0.00%)
At closeJul 25, 2023, 4:00 PM EDT
0.082 Day range 0.1395
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 10.80 +11377.2% upside
Now 0.0941
- Target (low)
- 6.00
- Target (mean)
- 10.80
- Target (high)
- 17.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
- 2 months ago 5
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.20 | -0.30 – -0.09 | -0.44 | +54.5% | 6.31M | +2.5% | 4 |
| Next quarter | -0.15 | -0.24 – -0.09 | -0.25 | +40.0% | 5.63M | +10.1% | 4 |
| Current year | -0.85 | -1.18 – -0.35 | -1.42 | +40.1% | 20.44M | -13.7% | 4 |
| Next year | -0.48 | -1.24 – 0.16 | -0.85 | +43.5% | 36.65M | +79.3% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 1, 2023 | Oppenheimer | Downgrade | Outperform | Perform |
| May 16, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 31, 2023 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 19, 2022 | Oppenheimer | Initiated | — | Outperform |
| Sep 24, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 9, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 14, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 4, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 22, 2021 | Roth Capital | Initiated | — | Buy |
| Jan 6, 2020 | H.C. Wainwright | Maintained | — | Buy |
| Oct 26, 2018 | H.C. Wainwright | Initiated | — | Buy |
| Jan 27, 2017 | Wedbush | Downgrade | Outperform | Neutral |
| Oct 17, 2016 | JMP Securities | Initiated | — | Market Outperform |